Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

about

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

Item

http://www.wikidata.org/entity/Q46299897

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@en

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@nl

type

Item

label

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@en

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@nl

prefLabel

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@en

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@nl

P1476

Confirmatory Testing Prior to Initiating Onychomycosis Therapy Is Cost-Effective.

@en

P2093

Aditya K Gupta

http://www.w3.org/2001/XMLSchema#string

Neil H Shear

http://www.w3.org/2001/XMLSchema#string

Sarah G Versteeg

http://www.w3.org/2001/XMLSchema#string

P2860

Malpractice risk according to physician specialty

Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis

Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.

Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.

Use of diagnostic tests by dermatologists, podiatrists and family practitioners in the United States: pilot data from a cross-sectional survey.

PAS is optimal for diagnosing onychomycosis.

Handling uncertainty in cost-effectiveness models.

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis.

P304

1203475417733461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1203475417733461

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28954534

http://www.w3.org/2001/XMLSchema#string